Related references
Note: Only part of the references are listed.Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue
Erika M. Wolff et al.
CANCER RESEARCH (2010)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of DNA methyltransferase 1 in hormone-resistant prostate cancer
Miao-Fen Chen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Drugs that Target Specificity Proteins Downregulate Epidermal Growth Factor Receptor in Bladder Cancer Cells
Gayathri Chadalapaka et al.
MOLECULAR CANCER RESEARCH (2010)
Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines
Herve Wallerand et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Updated results of bladder-sparing trimodality approach for invasive bladder cancer
Almudena Zapatero et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent manner
Thomas W. Flaig et al.
BJU INTERNATIONAL (2009)
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
Margaret A. Knowles et al.
CANCER AND METASTASIS REVIEWS (2009)
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
David J. McConkey et al.
CANCER AND METASTASIS REVIEWS (2009)
Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma
Rumi Hino et al.
CANCER RESEARCH (2009)
The promises and pitfalls of epigenetic therapies in solid tumours
Janet S. Graham et al.
EUROPEAN JOURNAL OF CANCER (2009)
Recurrence and Progression of Disease in Non-Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY (2009)
The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma
Miao-Fen Chen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response
Ramaswamy Bhuvaneswari et al.
MOLECULAR CANCER (2009)
Comparison of Global versus Epidermal Growth Factor Receptor Pathway Profiling for Prediction of Lapatinib Sensitivity in Bladder Cancer
Dmytro M. Havaleshko et al.
NEOPLASIA (2009)
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer
Wassim Kassouf et al.
JOURNAL OF UROLOGY (2008)
DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells
Mark V. Mishra et al.
MOLECULAR CANCER RESEARCH (2008)
Alterations of DNA methylation and clinicopathological diversity of human cancers
Yae Kanai
PATHOLOGY INTERNATIONAL (2008)
Demethylating agent 5-aza-2 '-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to cisplatin
Donghao Shang et al.
UROLOGY (2008)
Growth factors and receptors as prognostic markers in urothelial carcinoma
Peter C. Black et al.
Current Urology Reports (2008)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Trimodality treatment and selective organ preservation for bladder cancer
Claus Roedel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue
Pearlly S. Yan et al.
CLINICAL CANCER RESEARCH (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma
MG Friedrich et al.
EUROPEAN JOURNAL OF CANCER (2005)
DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis
T Nakagawa et al.
JOURNAL OF UROLOGY (2005)
Opinion - The role of apoptosis in cancer development and treatment response
JM Brown et al.
NATURE REVIEWS CANCER (2005)
Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy
JW Slaton et al.
JOURNAL OF UROLOGY (2004)
Phosphorylation of histone H2AX as a measure of radiosensitivity
PL Olive et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Biochemistry and biology of mammalian DNA methyltransferases
A Hermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach
D Gius et al.
CANCER CELL (2004)
Pathways of apoptotic and non-apoptotic death in tumour cells
H Okada et al.
NATURE REVIEWS CANCER (2004)
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients
MG Friedrich et al.
CLINICAL CANCER RESEARCH (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
MF Robert et al.
NATURE GENETICS (2003)
Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder
T Nakagawa et al.
JOURNAL OF UROLOGY (2003)
DNA methylation and chromatin - unraveling the tangled web
KD Robertson
ONCOGENE (2002)
The DNA methyltransferases of mammals
TH Bestor
HUMAN MOLECULAR GENETICS (2000)
Share Paper
